159 related articles for article (PubMed ID: 6189572)
1. Serum beta 2-microglobulin in malignant lymphoma.
Hagberg H; Killander A; Simonsson B
Cancer; 1983 Jun; 51(12):2220-5. PubMed ID: 6189572
[TBL] [Abstract][Full Text] [Related]
2. Serum beta 2 microglobulin in malignant lymphoproliferative disorders.
Constantinides IP; Pathouli C; Karvountzis G; Papadopoulos P; Varvoutsi-Constantinides M; Eliakis P; Hadziyannis S; Komninos Z
Cancer; 1985 May; 55(10):2384-9. PubMed ID: 3886124
[TBL] [Abstract][Full Text] [Related]
3. Serum beta 2-microglobulin in patients with non-Hodgkin's lymphoma.
Anderson H; Scarffe JH; Swindell R; Crowther D
Eur J Cancer Clin Oncol; 1983 Mar; 19(3):327-31. PubMed ID: 6190656
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.
Dimopoulos MA; Cabanillas F; Lee JJ; Swan F; Fuller L; Allen PK; Hagemeister FB
J Clin Oncol; 1993 Jun; 11(6):1108-11. PubMed ID: 8501496
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.
Litam P; Swan F; Cabanillas F; Tucker SL; McLaughlin P; Hagemeister FB; Rodriguez MA; Velasquez WS
Ann Intern Med; 1991 May; 114(10):855-60. PubMed ID: 2014946
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2 microglobulin and its prognostic value in lymphomas.
Amlot PL; Adinolfi M
Eur J Cancer (1965); 1979 May; 15(5):791-6. PubMed ID: 92408
[No Abstract] [Full Text] [Related]
7. Serum beta 2-microglobulin at remission and relapse in patients with multiple myeloma.
Brenning G; Wibell L; Bergström R
Eur J Clin Invest; 1985 Oct; 15(5):242-7. PubMed ID: 3935453
[TBL] [Abstract][Full Text] [Related]
8. A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
Swan F; Velasquez WS; Tucker S; Redman JR; Rodriguez MA; McLaughlin P; Hagemeister FB; Cabanillas F
J Clin Oncol; 1989 Oct; 7(10):1518-27. PubMed ID: 2674337
[TBL] [Abstract][Full Text] [Related]
9. [Beta 2 microglobulin].
Clément F
Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.
Kantarjian HM; Smith T; Estey E; Polyzos A; O'Brien S; Pierce S; Beran M; Feldman E; Keating MJ
Am J Med; 1992 Dec; 93(6):599-604. PubMed ID: 1466355
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
12. Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients.
Child JA; Spati B; Illingworth S; Barnard D; Corbett S; Simmons AV; Stone J; Worthy TS; Cooper EH
Cancer; 1980 Jan; 45(2):318-26. PubMed ID: 6153152
[No Abstract] [Full Text] [Related]
13. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
[TBL] [Abstract][Full Text] [Related]
14. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
[TBL] [Abstract][Full Text] [Related]
15. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
[TBL] [Abstract][Full Text] [Related]
16. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Stark P; Prokocimer M; Nativ HM; Kirgner I; Shaklai M
Leuk Lymphoma; 2003 Oct; 44(10):1733-8. PubMed ID: 14692526
[TBL] [Abstract][Full Text] [Related]
17. B2-microglobulin, a tumour marker of lymphoproliferative disorder.
Amlot PL; Adinolfi M
Lancet; 1978 Aug; 2(8087):476. PubMed ID: 79840
[No Abstract] [Full Text] [Related]
18. Pretreatment serum beta 2-microglobulin in multiple myeloma.
Brenning G; Simonsson B; Källander C; Ahre A
Br J Haematol; 1986 Jan; 62(1):85-93. PubMed ID: 3510657
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
